-
BitBiome to analyse gut bacteria related to cancer
biospectrumasia
December 09, 2019
BitBiome, Inc., a start-up company from?Waseda University in Japan,?and National Cancer Center of?Japan?have signed a collaborative research agreement on the analysis of gut bacteria related to cancer on?November 22nd.
-
Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer Patients
En-CPhI.CN
October 23, 2019
Cancer is the second leading cause of death globally and was responsible for over 9.6 million deaths in 2018 alone.
-
China's first self-developed carbon-ion therapy system gets market access
NMPA
October 16, 2019
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
-
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial
En-CPhI.CN
October 11, 2019
Datar Cancer Genetics, a cancer research company, today announced positive data from the phase II/III RESILIENT trial intended to validate clinical benefit for cancer patients ...
-
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
En-CPhI.CN
October 10, 2019
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer.
-
US researchers develop CAR T cell therapy for cancer
pharmaceutical-technology
September 27, 2019
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.
-
Prostate Cancer Risk Higher in Men Receiving Fertility Treatment
drugs
September 27, 2019
Men fathering children through assisted reproduction techniques rather than natural conception have an increased risk for prostate cancer, including early-onset disease, according to a study published online in The BMJ.
-
Researchers use three-drug combination to treat lung cancer
pharmaceutical-technology
September 26, 2019
A study by the Francis Crick Institute and The Institute of Cancer Research, London has tested the combination of a G12C KRAS inhibitor with mTOR and IGF1R inhibitors for the treatment of lung cancer.
-
Leukemia drug shows promise for treating a childhood brain cancer
worldpharmanews
September 25, 2019
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor ...
-
Study finds onion and garlic consumption may reduce breast cancer risk
worldpharmanews
September 24, 2019
Onions and garlic are key ingredients in sofrito, a condiment that's a staple of Puerto Rican cuisine. They may also be a recipe for reducing the risk of breast cancer.